Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Alzheimers Dement. 2016 Mar 24;12(9):942–951. doi: 10.1016/j.jalz.2016.02.009

Table 2.

Median DNA methylation levels by global features across tissues

# CpGs (Blood/Brain) T1 T2 Brain p Δ
Island features
Island 135,303/135,303 0.059 0.060 0.058 <0001
 North shore 55,328/55,328 0.481 0.485 0.442 <0001
 South shore 43,325/43,325 0.466 0.471 0.415 <0001
 North shelf 20,732/20,732 0.845 0.846 0.826 <0001
 South shelf 18,409/18,409 0.847 0.848 0.830 <0001
Gene features
 TSS1500 60,703/60,703 0.172 0.176 0.161 <0001
 TSS200 47,242/47,242 0.048 0.049 0.048 .031
 5’UTR 37,987/37,987 0.141 0.144 0.135 <0001
 1stExon 20,239/20,239 0.062 0.063 0.059 .002
 Gene body 141,917/141,917 0.817 0.819 0.755 <0001
 3’UTR 15,188/15,188 0.853 0.853 0.815 <0001
Chromatin structure*
 1_TssA 60,614/125,965 0.039 0.040 0.048 <0001
 2_TssAFlnk 41,806/21,400 0.093 0.095 0.187 <0001
 3_TxFlnk 29,974/872 0.037 0.038 0.497 <0001
 4_Tx 28,060/23,942 0.895 0.895 0.863 <0001
 5_TxWk 33,593/55,988 0.876 0.877 0.835 <0001
 6_EnhG 4,486/4399 0.856 0.858 0.701 <0001
 7_Enh 23,797/24,161 0.741 0.746 0.586 <0001
 8_ZNF/Rpts 894/702 0.852 0.851 0.673 <0001
 9_Het 2,119/1,528 0.805 0.805 0.806 0.775
 10_TssBiv 3,872/12,473 0.064 0.066 0.087 <0001
 11_BivFlnk 9,281/4,212 0.090 0.094 0.091 0.008
 12_EnhBiv 9,381/3,645 0.146 0.151 0.186 <0001
 13_ReprPC 15,708/17,536 0.254 0.263 0.264 <0001
 14_ReprPCWk 39,455/36,929 0.684 0.683 0.804 <0001
 15_Quies 117,092/86,380 0.841 0.841 0.848 <0001
*

1: Active TSS; 2: Flanking Active TSS; 3: Transcription at gene 5’ and 3’; 4: Strong transcription; 5: Weak transcription; 6: Genic enhancers; 7: Enhancers; 8: ZNF genes & repeats; 9: Heterochromatin; 10: Bivalent/Poised TSS; 11: Flanking Bivalent TSS/Enh: 12: Bivalent Enhancer; 13: Repressed PolyComb; 14: Weak Repressed PolyComb; 15: Quiescent/Low. Detailed description is reported previously [17].

Δ

Each p-value was derived from a non-parametric Kruskal-Wallis test which compares the difference of median methylation levels between T1, T2 and brain.